Cardiol Therapeutics
(NASDAQ) CRDL
Cardiol Therapeutics Financials at a Glance
Market Cap
$139.60M
Revenue (TTM)
$0.00
Net Income (TTM)
$32.29M
EPS (TTM)
$-0.30
P/E Ratio
-4.17
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Price
$1.17
Volume
46,458
Open
$1.24
Price
$1.17
Volume
46,458
Open
$1.24
Previous Close
$1.25
Daily Range
$1.16 - $1.27
52-Week Range
$0.77 - $1.59
Dividend
$0.00
Beta (Volatility)
1.45 (Average)
Price
$1.17
Volume
46,458
Open
$1.24
Previous Close
$1.25
Daily Range
$1.16 - $1.27
52-Week Range
$0.77 - $1.59
CRDL News
CRDL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cardiol Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
22
CEO
David G. Elsley, MBA
Website
www.cardiolrx.comHeadquarters
Oakville, ON L6H 0G5, CA
CRDL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-341%
Return on Capital
-4%
Return on Assets
-3%
Earnings Yield
-23.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$139.60M
Shares Outstanding
111.68M
Volume
46.46K
Short Interest
0.00%
Avg. Volume
479.66K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$40.28M
EBITDA
$40.11M
Operating Cash Flow
$25.06M
Capital Expenditure
$21.29K
Free Cash Flow
$25.08M
Cash & ST Invst.
$30.58M
Total Debt
$158.53K
Cardiol Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$139.60M
N/A
Market Cap/Employee
$7.76M
N/A
Employees
18
N/A
Net Income
$9.96M
+21.7%
EBITDA
$9.94M
+28.7%
Quarterly Fundamentals
Net Cash
$11.49M
-26.9%
Accounts Receivable
$195.88K
-26.6%
Inventory
$0.00
N/A
Long Term Debt
$97.27K
-27.5%
Short Term Debt
$36.92K
+16.2%
Return on Assets
-2.69%
N/A
Return on Invested Capital
-3.76%
N/A
Free Cash Flow
$6.93M
+10.9%
Operating Cash Flow
$6.93M
+10.9%